Mammary gland reprogramming: Metalloproteinases couple form with function

Cold Spring Harbor Perspectives in Biology

Volumn 3, Issue 4, 2011, Pages 1-19

  Khokha, Rama ^a   Werb, Zena ^b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

METALLOPROTEINASE;

ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MILK; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MAMMARY GLANDS, ANIMAL; METALLOPROTEASES; MILK;

EID: 84863876087     PISSN: None     EISSN: 19430264     Source Type: Journal    
DOI: 10.1101/cshperspect.a004333     Document Type: Article

References (135)

1. Affolter M, Bellusci S, Itoh N, Shilo B, Thiery JP, Werb Z. 2003. Tube or not tube: Remodeling epithelial tissues by branching morphogenesis. Dev Cell 4: 11-18.
2. Akbari A, Razzaghi Z, Homaee F, Khayamzadeh M, Movahedi M, Akbari ME. 2010. Parity and breastfeeding are preventive measures against breast cancer in Iranian women. Breast Cancer doi: 10.1007/s12282-010-0203-z.
3. Alexander CM, Reichsman F, Hinkes MT, Lincecum J, Becker KA, Cumberledge S, Bernfield M. 2000. Syndecan-1 is required for Wnt-1-induced mammary tumorigenesis in mice. Nat Genet 25: 329-332.
4. Alexander CM, Selvarajan S, Mudgett J, Werb Z. 2001. Stromelysin-1 regulates adipogenesis during mammary gland involution. J Cell Biol 152: 693-703.
5. Anderson CH, Beattie CW. 1992. Cellular kinetics of rat mammary gland terminal end bud epithelium exposed to N-methyl-N-nitrosourea in vivo. Cancer Res 52: 5076-5081.
6. Andrechek ER, White D, Muller WJ. 2005. Targeted disruption of ErbB2/Neu in the mammary epithelium results in impaired ductal outgrowth. Oncogene 24: 932-937.
7. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ, Visvader JE, Lindeman GJ. 2006. Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 98: 1011-1014.
8. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, et al. 2007. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminalcell differentiation. Nat Cell Biol 9: 201-209.
9. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, Yasuda H, Smyth GK, Martin TJ, Lindeman GJ, et al. 2010. Control of mammary stem cell function by steroid hormone signalling. Nature 465: 798-802.
10. Atabai K, Sheppard D, Werb Z. 2007. Roles of the innate immune system in mammary gland remodeling during involution. J Mammary Gland Biol Neoplasia 12: 37-45.
11. Barcellos-Hoff MH, Ewan KB. 2000. Transforming growth factor-β and breast cancer: Mammary gland development. Breast Cancer Res 2: 92-99.
12. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, et al. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744.
13. Blobel CP. 2005. ADAMs: Key components in EGFR signalling and development. Nat Rev Mol Cell Biol 6: 32-43.
14. Blobel CP, Carpenter G, Freeman M. 2009. The role of protease activity in ErbB biology. Exp Cell Res 315: 671-682.
15. Bonnette SG, Hadsell DL. 2001. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds. Endocrinology 142: 4937-4945.
16. Boudreau N, BissellMJ. 1998. Extracellular matrix signaling: Integration of form and function in normal and malignant cells. Curr Opin Cell Biol 10: 640-646.
17. Boulanger CA, Mack DL, Booth BW, Smith GH. 2007. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc Natl Acad Sci 104: 3871-3876.
18. Boyd NF, Martin LJ, Yaffe M, Minkin S. 2009. Mammographic density. Breast Cancer Res 11: S4.
19. Brisken C, Duss S. 2007. Stem cells and the stem cell niche in the breast: An integrated hormonal and developmental perspective. Stem Cell Rev 3: 147-156.
20. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA. 2000. Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 14: 650-654.
21. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly PA, Ormandy CJ. 1999. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 210: 96-106.
22. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. 1998. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci 95: 5076-5081.
23. Brown E, McKee T, diTomaso E, Pluen A, Seed B, Boucher Y, Jain RK. 2003. Dynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation. Nat Med 9: 796-800.
24. Butcher DT, Alliston T, Weaver VM. 2009. A tense situation: Forcing tumour progression. Nat Rev Cancer 9: 108-122.
25. Cardiff RD, Wellings SR. 1999. The comparative pathology of human and mouse mammary glands. J Mammary Gland Biol Neoplasia 4: 105-122.
26. Cheng N, Bhowmick NA, Chytil A, Gorksa AE, Brown KA, Muraoka R, Arteaga CL, Neilson EG, Hayward SW, Moses HL. 2005. Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-α-, MSPand HGF-mediated signaling networks. Oncogene 24: 5053-5068.
27. Chepko G, Dickson RB. 2003. Ultrastructure of the putative stem cell niche in rat mammary epithelium. Tissue Cell 35: 83-93.
28. Chou J, Provot S, Werb Z. 2010. GATA3 in development and cancer differentiation: Cells GATA have it! J Cell Physiol 222: 42-49.
29. Clarkson RW, Wayland MT, Lee J, Freeman T, Watson CJ. 2004. Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res 6: R92-R109.
30. Cruz-Munoz W, Khokha R. 2008. The role of tissue inhibitors of metalloproteinases in tumorigenesis and metastasis. Crit Rev Clin Lab Sci 45: 291-338.
31. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. 2003. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270.
32. Dunbar ME, Dann P, Brown CW, Van Houton J, Dreyer B, Philbrick WP, Wysolmerski JJ. 2001. Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. J Endocrinol 171: 403-416.
33. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
34. Ellerbroek SM, Stack MS. 1999. Membrane associated matrix metalloproteinases in metastasis. Bioessays 21: 940-949.
35. English JL, Kassiri Z, Koskivirta I, Atkinson SJ, Di Grappa M, Soloway PD, Nagase H, Vuorio E, Murphy G, Khokha R. 2006. Individual Timp deficiencies differentially impact pro-MMP-2 activation. J Biol Chem 281: 10337-10346.
36. Fata JE, ChaudharyV, Khokha R. 2001a. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol Reprod 65: 680-688.
37. Fata JE, Werb Z, Bissell MJ. 2004. Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes. Breast Cancer Res 6: 1-11.
38. Fata JE, Ho AT, Leco KJ, Moorehead RA, Khokha R. 2000a. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: Functions of metalloproteinases and their inhibitors. Cell Mol Life Sci 57: 77-95.
39. Fata JE, Kong YY, Li J, Sasaki T, Irie-Sasaki J, Moorehead RA, Elliott R, Scully S, Voura EB, Lacey DL, et al. 2000b. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103: 41-50.
40. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R. 1999. Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 211: 238-254.
41. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA, Khokha R. 2001b. Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108: 831-841.
42. Fitzgerald ML, Wang Z, Park PW, Murphy G, Bernfield M. 2000. Shedding of syndecan-1 and-4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase. J Cell Biol 148: 811-824.
43. Gouon-Evans V, Lin EY, Pollard JW. 2002. Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 4: 155-164.
44. Gouon-Evans V, Rothenberg ME, Pollard JW. 2000. Postnatal mammary gland development requires macrophages and eosinophils. Development 127: 2269-2282.
45. Green KA, Lund LR. 2005. ECM degrading proteases and tissue remodelling in the mammary gland. Bioessays 27: 894-903.
46. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, et al. 2001. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 61: 984-990.
47. Hens JR, Wysolmerski JJ. 2005. Key stages of mammary gland development: Molecular mechanisms involved in the formation of the embryonic mammary gland. Breast Cancer Res 7: 220-224.
48. Hinck L, Silberstein GB. 2005. Key stages in mammary gland development: The mammary end bud as a motile organ. Breast Cancer Res 7: 245-251.
49. Hojilla CV, Mohammed FF, Khokha R. 2003. Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br J Cancer 89: 1817-1821.
50. Hojilla CV, Kim I, Kassiri Z, Fata JE, Fang H, Khokha R. 2007. Metalloproteinase axes increase β-catenin signaling in primary mouse mammary epithelial cells lacking TIMP3. J Cell Sci 120: 1050-1060.
51. Horiuchi K., Kimura T., Miyamoto T, Takaishi H, Okada Y, Toyama Y, Blobel CP. 2007. Cutting edge: TNF-αconverting enzyme (TACE/ADAM17) inactivation in mouse myeloid cells prevents lethality from endotoxin shock. J Immunol 179: 2686-2689.
52. Humphreys RC, Lydon J, O'Malley BW, Rosen JM. 1997. Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol Endocrinol 11: 1-11.
53. IngmanWV, Wyckoff J, Gouon-EvansV, Condeelis J, Pollard JW. 2006. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland. Dev Dyn 235: 3222-3229.
54. Jackson-Fisher AJ, Bellinger G, Ramabhadran R, Morris JK, Lee KF, Stern DF. 2004. ErbB2 is required for ductal morphogenesis of the mammary gland. Proc Natl Acad Sci 101: 17138-17143.
55. Jenkins G. 2008. The role of proteases in transforming growth factor-beta activation. Int J Biochem Cell Biol 40: 1068-1078.
56. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, Stingl J, Waterhouse PD, Khokha R. 2010. Progesterone induces adult mammary stem cell expansion. Nature 465: 803-807.
57. Kamalati T, Niranjan B, Yant J, Buluwela L. 1999. HGF/SF in mammary epithelial growth and morphogenesis: In vitro and in vivo models. J Mammary Gland Biol Neoplasia 4: 69-77.
58. Kassiri Z, Defamie V, Hariri M, Oudit GY, Anthwal S, Dawood F, Liu P, Khokha R. 2009. Simultaneous transforming growth factor β-tumor necrosis factor activation and cross-talk cause aberrant remodeling response and myocardial fibrosis in Timp3-deficient heart. J Biol Chem 284: 29893-29904.
59. Keely PJ, Wu JE, Santoro SA. 1995. The spatial and temporal expression of the α2 β1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59: 1-13.
60. Kelsey JL, Gammon MD, John EM. 1993. Reproductive factors and breast cancer. Epidemiol Rev 15: 36-47.
61. Kessenbrock K, Plaks V, Werb Z. 2010. Matrix metalloproteinases: Regulators of the tumor microenvironment. Cell 141: 52-67.
62. Kleinberg DL, Feldman M, RuanW. 2000. IGF-I: An essential factor in terminal end bud formation and ductal morphogenesis. J Mammary Gland Biol Neoplasia 5: 7-17.
63. Kouros-Mehr H, Slorach EM, SternlichtMD, Werb Z. 2006. GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127: 1041-1055.
64. Lanigan F, O'Connor D, Martin F, Gallagher WM. 2007. Molecular links between mammary gland development and breast cancer. Cell Mol Life Sci 64: 3159-3184.
65. Lee EY, Parry G, Bissell MJ. 1984. Modulation of secreted proteins of mouse mammary epithelial cells by the collagenous substrata. J Cell Biol 98: 146-155.
66. Lilla JN, Joshi RV, Craik CS, Werb Z. 2009. Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution. J Biol Chem 284: 13792-13803.
67. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. 2008. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci 105: 1680-1685.
68. Lu P, Werb Z. 2008. Patterning mechanisms of branched organs. Science 322: 1506-1509.
69. Lu P, Sternlicht MD, Werb Z. 2006. Comparative mechanisms of branching morphogenesis in diverse systems. J Mammary Gland Biol Neoplasia 11: 213-228.
70. Lu P, Ewald AJ, Martin GR, Werb Z. 2008. Genetic mosaic analysis reveals FGF receptor 2 function in terminal end buds during mammary gland branching morphogenesis. Dev Biol 321: 77-87.
71. Luetteke NC, Qiu TH, Fenton SE, Troyer KL, Riedel RF, Chang A, Lee DC. 1999. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development. Development 126: 2739-2750.
72. Lund LR, Bjorn SF, Sternlicht MS, Nielsen BS, Solberg H, Usher PA, Osterby R, Christensen IJ, Stephens RW, Bugge TH, et al. 2000. Lactational competence and involution of the mouse mammary gland require plasminogen. Development 127: 4481-4492.
73. Lund LR, Romer J, Thomasset N, Solberg H, Pyke C, Bissell MJ, Dano K, Werb Z. 1996. Two distinct phases of apoptosis in mammary gland involution: Proteinase-independent and-dependent pathways. Development 122: 181-193.
74. Mallepell S, Krust A, Chambon P, Brisken C. 2006. Paracrine signaling through the epithelial estrogen receptor α is required for proliferation and morphogenesis in the mammary gland. Proc Natl Acad Sci 103: 2196-2201.
75. Martin DC, Fowlkes JL, Babic B, Khokha R. 1999. Insulinlike growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1. J Cell Biol 146: 881-892.
76. McClellan HL, Miller SJ, Hartmann PE. 2008. Evolution of lactation:Nutrition v. protectionwith special reference to five mammalian species. Nutr Res Rev 21: 97-116.
77. Mohammed FF, Khokha R. 2005. Thinking outside the cell: Proteases regulate hepatocyte division. Trends Cell Biol 15: 555-563.
78. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, Khokha R. 2005. Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGFactivation in murine liver regeneration. Hepatology 41: 857-867.
79. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, English JL, Matrisian LM, Au B, Yeh WC, et al. 2004. Abnormal TNF activity in Timp3-/-mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet 36: 969-977.
80. Monks J, Smith-Steinhart C, Kruk ER, Fadok VA, Henson PM. 2008. Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod 78: 586-594.
81. Mori H, Gjorevski N, Inman JL, Bissell MJ, Nelson CM. 2009. Self-organization of engineered epithelial tubules by differential cellular motility. Proc Natl Acad Sci 106: 14890-14895.
82. Murphy G. 2008. The ADAMs: Signalling scissors in the tumour microenvironment. Nat Rev Cancer 8: 929-941.
83. Murphy G, Nagase H. 2008. Progress in matrix metalloproteinase research. Mol Aspects Med 29: 290-308.
84. Murphy G, Murthy A, Khokha R. 2008. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 29: 75-82.
85. Murthy A, Defamie V, Smookler DS, Di Grappa MA, Horiuchi K, Federici M, Sibilia M, Blobel CP, Khokha R. 2010. Ectodomain shedding of EGFR ligands and TNFR1 dictates hepatocyte apoptosis during fulminant hepatitis in mice. J Clin Invest 120: 2731-2744.
86. Neville MC, McFadden TB, Forsyth I. 2002. Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 7: 49-66.
87. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M. 2001. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 114: 111-118.
88. O'Brien J, Schedin P. 2009. Macrophages in breast cancer: Do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia 14: 145-157.
89. Oakes SR, Rogers RL, Naylor MJ, Ormandy CJ. 2008. Prolactin regulation of mammary gland development. J Mammary Gland Biol Neoplasia 13: 13-28.
90. OftedalOT. 2002. The mammary gland and its origin during synapsid evolution. J Mammary Gland Biol Neoplasia 7: 225-252.
91. Page-McCawA, Ewald AJ, Werb Z. 2007. Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8: 221-233.
92. Pang WW, Hartmann PE. 2007. Initiation of human lactation: Secretory differentiation and secretory activation. J Mammary Gland Biol Neoplasia 12: 211-221.
93. Pollard JW, Hennighausen L. 1994. Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci 91: 9312-9316.
94. Radisky DC, Hartmann LC. 2009. Mammary involution and breast cancer risk: Transgenic models and clinical studies. J Mammary Gland Biol Neoplasia 14: 181-191.
95. Radisky DC, Hirai Y, Bissell MJ. 2003. Delivering the message: Epimorphin and mammary epithelial morphogenesis. Trends Cell Biol 13: 426-434.
96. Richards RG, Klotz DM, Walker MP, Diaugustine RP. 2004. Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in micewith a liver-specific deletion of IGF-I. Endocrinology 145: 3106-3110.
97. Robinson GW. 2007. Cooperation of signalling pathways in embryonic mammary gland development. Nat Rev Genet 8: 963-972.
98. Robinson GW, McKnight RA, Smith GH, Hennighausen L. 1995. Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development 121: 2079-2090.
99. Rossiter H, Barresi C, Ghannadan M, Gruber F, Mildner M, Fodinger D, Tschachler E. 2007. Inactivation of VEGF in mammary gland epithelium severely compromises mammary gland development and function. FASEB J 21: 3994-4004.
100. Ruan W, Monaco ME, Kleinberg DL. 2005. Progesterone stimulates mammary gland ductal morphogenesis by synergizing with and enhancing insulin-like growth factor-I action. Endocrinology 146: 1170-1178.
101. Schedin P, Mitrenga T, McDaniel S, Kaeck M. 2004. Mammary ECM composition and function are altered by reproductive state. Mol Carcinog 41: 207-220.
102. Schenk S, Hintermann E, Bilban M, Koshikawa N, Hojilla C, Khokha R, Quaranta V. 2003. Binding to EGF receptor of a laminin-5 EGF-like fragment liberated during MMP-dependent mammary gland involution. J Cell Biol 161: 197-209.
103. Sebastian J, Richards RG, Walker MP, Wiesen JF, Werb Z, Derynck R, Hom YK, Cunha GR, DiAugustine RP. 1998. Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis. Cell Growth Differ 9: 777-785.
104. Serra R, Crowley MR. 2005. Mouse models of transforming growth factor β impact in breast development and cancer. Endocr Relat Cancer 12: 749-760.
105. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. 2006. Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88.
106. Simian M, Bissell MJ, Barcellos-Hoff MH, Shyamala G. 2009. Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice. Breast Cancer Res 11: R72.
107. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, Khokha R. 2006. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol 176: 721-725.
108. Sorrell DA, Szymanowska M, Boutinaud M, Robinson C, Clarkson RW, Stein T, Flint DJ, Kolb AF. 2005. Regulation of genes encoding proteolytic enzymes during mammary gland development. J Dairy Res 72: 433-441.
109. Srinivasan K, Strickland P, Valdes A, Shin GC, Hinck L. 2003. Netrin-1/neogenin interaction stabilizes multipotent progenitor cap cells during mammary gland morphogenesis. Dev Cell 4: 371-382.
110. Stein T, Morris JS, Davies CR, Weber-Hall SJ, Duffy MA, Heath VJ, Bell AK, Ferrier RK, Sandilands GP, Gusterson BA. 2004. Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res 6: R75-R91.
111. Sternlicht MD. 2006. Key stages in mammary gland development: The cues that regulate ductal branching morphogenesis. Breast Cancer Res 8: 201.
112. Sternlicht MD, Kouros-Mehr H, Lu P, Werb Z. 2006. Hormonal and local control of mammary branching morphogenesis. Differentiation 74: 365-381.
113. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146.
114. Sternlicht MD, Sunnarborg SW, Kouros-Mehr H, Yu Y, Lee DC, Werb Z. 2005. Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin. Development 132: 3923-3933.
115. Stingl J, Raouf A, Emerman JT, Eaves CJ. 2005. Epithelial progenitors in the normal human mammary gland. J Mammary Gland Biol Neoplasia 10: 49-59.
116. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. 2006a. Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997.
117. Stingl J, Raouf A, Eirew P, Eaves CJ. 2006b. Deciphering the mammary epithelial cell hierarchy. Cell Cycle 5: 1519-1522.
118. Talhouk RS, Bissell MJ, Werb Z. 1992. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol 118: 1271-1282.
119. Talhouk RS, Chin JR, Unemori EN, Werb Z, Bissell MJ. 1991. Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 112: 439-449.
120. Tidcombe H, Jackson-Fisher A, Mathers K, Stern DF, Gassmann M, Golding JP. 2003. Neural and mammary gland defects in ErbB4 knockout mice genetically rescued from embryonic lethality. Proc Natl Acad Sci 100: 8281-8286.
121. Turashvili G, Bouchal J, Burkadze G, Kolar Z. 2006. Wnt signaling pathway in mammary gland development and carcinogenesis. Pathobiology 73: 213-223.
122. Ursin G, Parisky YR, Pike MC, Spicer DV. 2001. Mammographic density changes during the menstrual cycle. Cancer Epidemiol Biomarkers Prev 10: 141-142.
123. Veronesi U, Boyle P, Goldhirsch A, Orecchia R, Viale G. 2005. Breast cancer. Lancet 365: 1727-1741.
124. Vorbach C, Capecchi MR, Penninger JM. 2006. Evolution of the mammary gland from the innate immune system? Bioessays 28: 606-616.
125. Walker NI, Bennett RE, Kerr JF. 1989. Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 185: 19-32.
126. Watson CJ. 2006. Involution: apoptosis and tissue remodelling that convert the mammary gland from milk factory to a quiescent organ. Breast Cancer Res 8: 203.
127. Watson CJ, Khaled WT. 2008. Mammary development in the embryo and adult: A journey of morphogenesis and commitment. Development 135: 995-1003.
128. Weskamp G, Ford JW, Sturgill J, Martin S, Docherty AJ, Swendeman S, Broadway N, Hartmann D, Saftig P, Umland S, et al. 2006. ADAM10 is a principal 'sheddase' of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 7: 1293-1298.
129. Widelitz RB, Veltmaat JM, Mayer JA, Foley J, Chuong CM. 2007. Mammary glands and feathers: comparing two skin appendages which help define novel classes during vertebrate evolution. Semin Cell Dev Biol 18: 255-266.
130. Wilkins-Port CE, Higgins PJ. 2007. Regulation of extracellular matrix remodeling following transforming growth factor-β1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs 185: 116-122.
131. Wiseman BS, SternlichtMD, Lund LR, Alexander CM, Mott J, Bissell MJ, Soloway P, Itohara S, Werb Z. 2003. Sitespecific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol 162: 1123-1133.
132. Wiseman BS, Werb Z. 2002. Stromal effects on mammary gland development and breast cancer. Science 296: 1046-1049.
133. Witty JP, Wright JH, Matrisian LM. 1995. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 6: 1287-1303.
134. Xu R, Boudreau A, Bissell MJ. 2009. Tissue architecture and function: dynamic reciprocity via extra-and intracellular matrices. Cancer Metastasis Rev 28: 167-176.
135. Zarzynska J, Motyl T. 2008. Apoptosis and autophagy in involuting bovine mammary gland. J Physiol Pharmacol 59: 275-288.